US Patent Issued to KYMAB on Oct. 7 for "Antagonists anti-CD7 antibodies" (British Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,134, issued on Oct. 7, was assigned to KYMAB Ltd. (Cambridge, Great Britain).

"Antagonists anti-CD7 antibodies" was invented by E-Chiang Lee (Cambridge, Great Britain), Gwenoline Borhis (Cambridge, Great Britain), Cassandra Van Krinks (Cambridge, Great Britain), Lucy Hepburn (Cambridge, Great Britain), Luke Bayliss (Cambridge, Great Britain) and Miha Kosmac (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to Cluster of Differentiation 7 (CD7) antagonists, such as antibodies and fragments, as well as methods, uses and combinations."

The patent was filed on April 17, 2020, under Application No. 17/604,209....